CD14 is a glycophosphatidylinositol-linked protein expressed by myeloid cel
ls and also circulates as a plasma protein lacking the glycophosphatidylino
sitol anchor. Both membrane and soluble CD14 function to enhance activation
of cells by lipopolysaccharide (LPS), which we refer to as receptor functi
on. We have previously reported the LPS binding and cell activation functio
ns of a group of five deletion mutants of CD14 (Viriyakosol, S., and Kirkla
nd, T.N. (1995) J. Biol. Chem. 270, 361-368). We have now studied the funct
ional impact of these mutations on soluble CD14. We found that some deletio
ns that abrogated LPS binding in membrane CD14 have no effect on LPS bindin
g in soluble CD14. In fact, some of the soluble CD14 deletion mutants bound
LPS with an apparent higher affinity than wild-type CD14. Furthermore, we
found that all five deletions essentially ablated soluble CD14 LPS receptor
function, whereas only two of the deletions completely destroyed membrane
CD14 LPS receptor function. Some of the mutants were able to compete with w
ild-type CD14 in soluble CD14-dependent assays of cellular activation. We c
oncluded that the soluble and membrane forms of CD14 have different structu
ral determinants for LPS receptor function.